Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Revenue

Ironwood Pharmaceuticals had revenue of $91.59M in the quarter ending September 30, 2024, a decrease of -19.47%. This brings the company's revenue in the last twelve months to $378.42M, down -12.48% year-over-year. In the year 2023, Ironwood Pharmaceuticals had annual revenue of $442.74M with 7.83% growth.

• Revenue (ttm): $378.42M
• Revenue Growth: -12.48%
• P/S Ratio: 1.47
• Revenue / Employee: $1,417,296
• Employees: 267
• Market Cap: 563.30M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	442.74M	32.14M	7.83%
Dec 31, 2022	410.60M	-3.16M	-0.76%
Dec 31, 2021	413.75M	24.23M	6.22%
Dec 31, 2020	389.52M	-38.89M	-9.08%
Dec 31, 2019	428.41M	81.77M	23.59%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.